Doctor of Optometry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Pamela Lowe

Optometrist Chicago, IL Doctor of Optometry

NPI 1851484620 CMS profile 786192

6325 N Milwaukee Ave, Chicago, IL 60646

Open in the dashboard

General payments

$446,604

933 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Pamela Lowe of Chicago, IL is reported in the CMS Open Payments database as having received $446,604 across 933 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Optometrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $55,774 140
2024 General $40,330 98
2023 General $52,160 108
2022 General $53,717 99
2021 General $90,225 205
2020 General $31,271 46
2019 General $123,127 237

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Pamela Lowe
  • Optometrist median
  • Middle half of Optometrist
  • National median

In program year 2025, general payments to Pamela Lowe were reported at $55,774. Among 35,373 Optometrist profiles paid that year, the median was $204 and the middle half received between $87 and $464.

Show as a table
Year Pamela Lowe Optometrist median Middle half National median
2019 $123,127 $159 $67–$371 $163
2020 $31,271 $72 $29–$165 $114
2021 $90,225 $125 $46–$292 $132
2022 $53,717 $162 $66–$374 $149
2023 $52,160 $177 $72–$406 $160
2024 $40,330 $188 $77–$427 $164
2025 $55,774 $204 $87–$464 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Alcon Vision LLC $389,882 858 payments
  2. MacuLogix, Inc. $54,081 27 payments
  3. CooperVision Inc. $1,289 19 payments
  4. Optos, Inc. $374 9 payments
  5. Visionix USA, Inc $362 1 payment
  6. Bausch & Lomb, a division of Bausch Health US, LLC $159 5 payments
  7. ABB Con-Cise Optical Group LLC $119 3 payments
  8. Allergan Inc. $101 1 payment
  9. Sight Sciences, Inc. $75 1 payment
  10. Bausch & Lomb Americas Inc. $54 3 payments
  11. Other $108 6 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $273,885 204 payments
  2. Travel and Lodging $77,537 462 payments
  3. Honoraria $37,006 10 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $30,958 18 payments
  5. Food and Beverage $27,033 233 payments
  6. Entertainment $184 6 payments
Products named General payments · program years 2019–2025
  1. TOTAL30 $175,630 387 payments
  2. Precision 1 $127,348 262 payments
  3. DAILIES TOTAL1 $119,582 230 payments
  4. DAILIES $90,571 193 payments
  5. AdaptDx $54,081 27 payments
  6. Systane $20,869 43 payments
  7. AIR OPTIX $20,568 61 payments
  8. Dailies Aqua Comfort Plus $9,035 28 payments
  9. Precision7 $8,692 24 payments
  10. DAILIES TOTAL1 Multifocal $8,311 26 payments
  11. Other $8,772 94 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 19 billing codes

Paid by Medicare

$25,640

Medicare's payments for the services billed

Medicare patients

177

Average age 73

Services billed

1,253

115 women, 62 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 61%
Arthritis 45%
Ischemic heart disease 21%
Diabetes 19%
Osteoporosis 18%
Cancer 12%
Atrial fibrillation 11%
Depression 11%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

933 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Optometrist in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record